Bausch Health Companies Inc. - (BHC.TO) - January 14, 2021

by SIACharts.com

Specialty and generic pharmaceutical producer Bausch Health (BHC.TO) has returned to the Green Favored Zone of the SIA S&P/TSX 60 Index report for the first time in nearly a year. The shares climbed 11 spots yesterday in response to positive sales guidance to 12th place and have moved up 31 places in the last month.

Accumulation in Bausch Health (BHC.TO) shares continues to accelerate. Since a successful retest of $20.00 support back in September, the shares have not looked back with the slope of their uptrend increasing and the shares staging a series of successful breakouts. These include: snapping out of a downtrend in November, completing a bullish Ascending Triangle base with a breakout over $27.50 in December, and breaking through the top of a $20.00 to $30.00 sideways range this month.

Next potential upside resistance tests on trend appear near $37.50 then $40.00 and $42.50 where measured moves converge with previous highs/lows and a round number. Initial support appears near $30.00 a round number and recent breakout point.

A major breakout is underway in Bausch Health (BHC.TO) shares which have broken out of a base that had been forming since March by clearing $27.61, snapped out of a long-term downtrend and regained the $30.00 level so far this month, all combining to indicate increased accumulation and the start of a new uptrend.

Next potential upside resistance tests on trend appear near $35.70 and $42.70 where horizontal counts converge with previous column highs. Initial support appears near $29.30 based on a 3-box reversal.

With a bullish SMAX score of 8, BHC.TO is exhibiting near-term strength against the asset classes.

 
 
 

Disclaimer: SIACharts Inc. specifically represents that it does not give investment advice or advocate the purchase or sale of any security or investment whatsoever. This information has been prepared without regard to any particular investors investment objectives, financial situation, and needs. None of the information contained in this document constitutes an offer to sell or the solicitation of an offer to buy any security or other investment or an offer to provide investment services of any kind. As such, advisors and their clients should not act on any recommendation (express or implied) or information in this report without obtaining specific advice in relation to their accounts and should not rely on information herein as the primary basis for their investment decisions. Information contained herein is based on data obtained from recognized statistical services, issuer reports or communications, or other sources, believed to be reliable. SIACharts Inc. nor its third party content providers make any representations or warranties or take any responsibility as to the accuracy or completeness of any recommendation or information contained herein and shall not be liable for any errors, inaccuracies or delays in content, or for any actions taken in reliance thereon. Any statements nonfactual in nature constitute only current opinions, which are subject to change without notice.

Total
0
Shares
Previous Article

Tactical asset allocation ā€” December 2020 recap

Next Article

#MacroView: El-Erian & The Two Primary Risks In 2021

Related Posts
Subscribe to AdvisorAnalyst.com notifications
Watch. Listen. Read. Raise your average.